LIVIVO - Search results -

Search results

Result 1 - 10 of total 21

Search options

Article: L'éducation thérapeutique du patient.

Pierre, Stéphanie

2013 , Issue 193, Page(s) 53–54

Title translation	Therapeutic education of the patient.
MeSH term(s)	Chronic Disease/nursing ; Chronic Disease/psychology ; Humans ; Nursing Assessment ; Patient Education as Topic/organization & administration ; Patient-Centered Care ; Quality of Life/psychology ; Self Care
Language	French
Publishing date	2013-09-16
Publishing country	France
Document type	Journal Article
ZDB-ID	632538-5
ISSN	1293-8505 ; 0397-7900
ISSN	1293-8505 ; 0397-7900
DOI	10.1016/j.revinf.2013.06.002
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.B 2782: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Challenges and solutions for therapeutic TCR-based agents.

Malviya, Manish / Aretz, Zita E H / Molvi, Zaki / Lee, Jayop / Pierre, Stephanie / Wallisch, Patrick / Dao, Tao / Scheinberg, David A

Immunological reviews

2023 Volume 320, Issue 1, Page(s) 58–82

Abstract: Recent development of methods to discover and engineer therapeutic T-cell receptors (TCRs) or antibody mimics of TCRs, and to understand their immunology and pharmacology, lag two decades behind therapeutic antibodies. Yet we have every expectation that ... ...

Abstract	Recent development of methods to discover and engineer therapeutic T-cell receptors (TCRs) or antibody mimics of TCRs, and to understand their immunology and pharmacology, lag two decades behind therapeutic antibodies. Yet we have every expectation that TCR-based agents will be similarly important contributors to the treatment of a variety of medical conditions, especially cancers. TCR engineered cells, soluble TCRs and their derivatives, TCR-mimic antibodies, and TCR-based CAR T cells promise the possibility of highly specific drugs that can expand the scope of immunologic agents to recognize intracellular targets, including mutated proteins and undruggable transcription factors, not accessible by traditional antibodies. Hurdles exist regarding discovery, specificity, pharmacokinetics, and best modality of use that will need to be overcome before the full potential of TCR-based agents is achieved. HLA restriction may limit each agent to patient subpopulations and off-target reactivities remain important barriers to widespread development and use of these new agents. In this review we discuss the unique opportunities for these new classes of drugs, describe their unique antigenic targets, compare them to traditional antibody therapeutics and CAR T cells, and review the various obstacles that must be overcome before full application of these drugs can be realized.
MeSH term(s)	Humans ; Receptors, Antigen, T-Cell/metabolism ; Neoplasms/therapy ; Antibodies
Chemical Substances	Receptors, Antigen, T-Cell ; Antibodies
Language	English
Publishing date	2023-07-16
Publishing country	England
Document type	Journal Article ; Review
ZDB-ID	391796-4
ISSN	1600-065X ; 0105-2896
ISSN (online)	1600-065X
ISSN	0105-2896
DOI	10.1111/imr.13233
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Se 160: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: Challenges and solutions for therapeutic TCR‐based agents

Malviya, Manish / Aretz, Zita E. H. / Molvi, Zaki / Lee, Jayop / Pierre, Stephanie / Wallisch, Patrick / Dao, Tao / Scheinberg, David A.

Immunological Reviews. 2023 Nov., v. 320, no. 1 p.58-82

2023

Abstract: Recent development of methods to discover and engineer therapeutic T‐cell receptors (TCRs) or antibody mimics of TCRs, and to understand their immunology and pharmacology, lag two decades behind therapeutic antibodies. Yet we have every expectation that ... ...

Abstract	Recent development of methods to discover and engineer therapeutic T‐cell receptors (TCRs) or antibody mimics of TCRs, and to understand their immunology and pharmacology, lag two decades behind therapeutic antibodies. Yet we have every expectation that TCR‐based agents will be similarly important contributors to the treatment of a variety of medical conditions, especially cancers. TCR engineered cells, soluble TCRs and their derivatives, TCR‐mimic antibodies, and TCR‐based CAR T cells promise the possibility of highly specific drugs that can expand the scope of immunologic agents to recognize intracellular targets, including mutated proteins and undruggable transcription factors, not accessible by traditional antibodies. Hurdles exist regarding discovery, specificity, pharmacokinetics, and best modality of use that will need to be overcome before the full potential of TCR‐based agents is achieved. HLA restriction may limit each agent to patient subpopulations and off‐target reactivities remain important barriers to widespread development and use of these new agents. In this review we discuss the unique opportunities for these new classes of drugs, describe their unique antigenic targets, compare them to traditional antibody therapeutics and CAR T cells, and review the various obstacles that must be overcome before full application of these drugs can be realized.
Keywords	T-lymphocytes ; antibodies ; patients ; pharmacokinetics ; therapeutics
Language	English
Dates of publication	2023-11
Size	p. 58-82.
Publishing place	John Wiley & Sons, Ltd
Document type	Article ; Online
Note	REVIEW
ZDB-ID	391796-4
ISSN	1600-065X ; 0105-2896
ISSN (online)	1600-065X
ISSN	0105-2896
DOI	10.1111/imr.13233
Database	NAL-Catalogue (AGRICOLA)

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Se 160: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article: La captation audio dans le dispositif hybride de la formation infirmière: contribution à l'acquisition des connaissances pour le développement de compétences professionnelles.

Hoyelle-Pierre, Stéphanie / Villemonteix, François

Recherche en soins infirmiers

2015 , Issue 123, Page(s) 108–116

Abstract: This article deals with the results of a probing study in the framework of the education and technology master of research in educational science of the university of Cergy-Pontoise. This study focuses on the use of audio capture by first year nursing ... ...

Title translation	Audio capture in the hybrid system of nursing training: contribution to the acquisition of knowledge for the development of professional skills.
Abstract	This article deals with the results of a probing study in the framework of the education and technology master of research in educational science of the university of Cergy-Pontoise. This study focuses on the use of audio capture by first year nursing students in the development of their knowledge and therefore in the development of their professional skills. By using the model of the unified theory of acceptance and use of technology (UTAUT), the results of this study have helped to identify the levers (easy-to-use digital resources, computer skilled learners, multiplicity of computer equipment of the learners) and bridles (the relative gain when using this resource, the lack of human interaction, a resource which is time consuming) in the use of audio capture. A more extensive study could focus on these bridles in order to promote the use of audio capture by learners in the hybrid system of nursing training.
MeSH term(s)	Adolescent ; Adult ; Age Factors ; Audiovisual Aids ; Education, Nursing/methods ; France ; Humans ; Middle Aged ; Nursing Informatics ; Young Adult
Language	French
Publishing date	2015-12
Publishing country	France
Document type	English Abstract ; Journal Article
ISSN	0297-2964
ISSN	0297-2964
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Black in Cancer: Two Years of Empowering the Next Generation.

Bourne, Christopher M / Henderson, Henry J / White, Elshaddai / Morris, Julia / Bah, Mamadou A / Harewood, Rhea / Pierre, Stephanie / Martins, Tanimola / Ntereke, Tumisang / White, Briana / Bonner, Sigourney

Cancer discovery

2023 Volume 13, Issue 2, Page(s) 275–277

Abstract: In the 2 years since the inception of Black in Cancer, we have modeled an action-oriented commitment to improving Black representation across all levels of the cancer spectrum. We reflect on our successes and consider new ways to innovate and inspire the ...

Abstract	In the 2 years since the inception of Black in Cancer, we have modeled an action-oriented commitment to improving Black representation across all levels of the cancer spectrum. We reflect on our successes and consider new ways to innovate and inspire the cancer community.
MeSH term(s)	Humans ; Neoplasms ; Power, Psychological
Language	English
Publishing date	2023-01-30
Publishing country	United States
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	2625242-9
ISSN	2159-8290 ; 2159-8274
ISSN (online)	2159-8290
ISSN	2159-8274
DOI	10.1158/2159-8290.CD-22-1408
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 6916: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: Host-cell Interactions of Engineered T cell Micropharmacies.

Bourne, Christopher M / Wallisch, Patrick / Dacek, Megan / Gardner, Thomas / Pierre, Stephanie / Vogt, Kristen / Corless, Broderick C / Bah, Mamadou A / Romero Pichardo, Jesus / Charles, Angel / Kurtz, Keifer G / Tan, Derek S / Scheinberg, David A

bioRxiv : the preprint server for biology

2023

Abstract: Genetically engineered, cytotoxic, adoptive T cells localize to antigen positive cancer cells inside patients, but tumor heterogeneity and multiple immune escape mechanisms have prevented the eradication of most solid tumor types. More effective, ... ...

Abstract	Genetically engineered, cytotoxic, adoptive T cells localize to antigen positive cancer cells inside patients, but tumor heterogeneity and multiple immune escape mechanisms have prevented the eradication of most solid tumor types. More effective, multifunctional engineered T cells are in development to overcome the barriers to the treatment of solid tumors, but the interactions of these highly modified cells with the host are poorly understood. We previously engineered prodrug-activating enzymatic functions into chimeric antigen receptor (CAR) T cells, endowing them with an orthogonal killing mechanism to conventional T-cell cytotoxicity. These drug-delivering cells, termed Synthetic Enzyme-Armed KillER (SEAKER) cells, demonstrated efficacy in mouse lymphoma xenograft models. However, the interactions of an immunocompromised xenograft with such complex engineered T cells are distinct from those in an immunocompetent host, precluding an understanding of how these physiologic processes may affect the therapy. Here, we also expand the repertoire of SEAKER cells to target solid-tumor melanomas in syngeneic mouse models using specific targeting with TCR-engineered T cells. We demonstrate that SEAKER cells localize specifically to tumors, and activate bioactive prodrugs, despite host immune responses. We additionally show that TCR-engineered SEAKER cells are efficacious in immunocompetent hosts, demonstrating that the SEAKER platform is applicable to many adoptive cell therapies.
Language	English
Publishing date	2023-05-01
Publishing country	United States
Document type	Preprint
DOI	10.1101/2023.04.05.535717
Database	MEDical Literature Analysis and Retrieval System OnLINE

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Details ▾

Article ; Online: Host Interactions with Engineered T-cell Micropharmacies.

Bourne, Christopher M / Wallisch, Patrick / Dacek, Megan M / Gardner, Thomas J / Pierre, Stephanie / Vogt, Kristen / Corless, Broderick C / Bah, Mamadou A / Romero-Pichardo, Jesus E / Charles, Angel / Kurtz, Keifer G / Tan, Derek S / Scheinberg, David A

Cancer immunology research

2023 Volume 11, Issue 9, Page(s) 1253–1265

Abstract: Genetically engineered, cytotoxic, adoptively transferred T cells localize to antigen-positive cancer cells inside patients, but tumor heterogeneity and multiple immune escape mechanisms have prevented the eradication of most solid tumor types. More ... ...

Abstract	Genetically engineered, cytotoxic, adoptively transferred T cells localize to antigen-positive cancer cells inside patients, but tumor heterogeneity and multiple immune escape mechanisms have prevented the eradication of most solid tumor types. More effective, multifunctional engineered T cells are in development to overcome the barriers to the treatment of solid tumors, but the interactions of these highly modified cells with the host are poorly understood. We previously engineered prodrug-activating enzymatic functions into chimeric antigen receptor (CAR) T cells, endowing them with a killing mechanism orthogonal to conventional T-cell cytotoxicity. These drug-delivering cells, termed Synthetic Enzyme-Armed KillER (SEAKER) cells, demonstrated efficacy in mouse lymphoma xenograft models. However, the interactions of an immunocompromised xenograft with such complex engineered T cells are distinct from those in an immunocompetent host, precluding an understanding of how these physiologic processes may affect the therapy. Herein, we expanded the repertoire of SEAKER cells to target solid-tumor melanomas in syngeneic mouse models using specific targeting with T-cell receptor (TCR)-engineered T cells. We demonstrate that SEAKER cells localized specifically to tumors, and activated bioactive prodrugs, despite host immune responses. We additionally show that TCR-engineered SEAKER cells were efficacious in immunocompetent hosts, demonstrating that the SEAKER platform is applicable to many adoptive cell therapies.
MeSH term(s)	Mice ; Animals ; Humans ; Immunotherapy, Adoptive ; T-Lymphocytes, Cytotoxic ; Genetic Engineering ; Melanoma ; Receptors, Antigen, T-Cell/genetics
Chemical Substances	Receptors, Antigen, T-Cell
Language	English
Publishing date	2023-07-17
Publishing country	United States
Document type	Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
ZDB-ID	2732489-8
ISSN	2326-6074 ; 2326-6066
ISSN (online)	2326-6074
ISSN	2326-6066
DOI	10.1158/2326-6066.CIR-22-0879
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 7022: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Potentiating antibody-dependent killing of cancers with CAR T cells secreting CD47-SIRPα checkpoint blocker.

Dacek, Megan M / Kurtz, Keifer G / Wallisch, Patrick / Pierre, Stephanie A / Khayat, Shireen / Bourne, Christopher M / Gardner, Thomas J / Vogt, Kristen C / Aquino, Nica / Younes, Anas / Scheinberg, David A

Blood

2023 Volume 141, Issue 16, Page(s) 2003–2015

Abstract: Chimeric antigen receptor (CAR) T-cell therapy has shown success in the treatment of hematopoietic malignancies; however, relapse remains a significant issue. To overcome this, we engineered "Orexi" CAR T cells to locally secrete a high-affinity CD47 ... ...

Abstract	Chimeric antigen receptor (CAR) T-cell therapy has shown success in the treatment of hematopoietic malignancies; however, relapse remains a significant issue. To overcome this, we engineered "Orexi" CAR T cells to locally secrete a high-affinity CD47 blocker, CV1, at the tumor and treated tumors in combination with an orthogonally targeted monoclonal antibody. Traditional CAR T cells plus the antibody had an additive effect in xenograft models, and this effect was potentiated by CAR T-cell local CV1 secretion. Furthermore, OrexiCAR-secreted CV1 reversed the immunosuppression of myelomonocytoid cells both in vitro and within the tumor microenvironment. Local secretion of the CD47 inhibitor bypasses the CD47 sink found on all cells in the body and may prevent systemic toxicities. This combination of CAR T-cell therapy, local CD47 blockade, and orthogonal antibody may be a combinatorial strategy to overcome the limitations of each monotherapy.
MeSH term(s)	Humans ; CD47 Antigen ; Neoplasm Recurrence, Local ; Neoplasms/pathology ; T-Lymphocytes ; Immunotherapy, Adoptive ; Antibodies, Monoclonal/therapeutic use ; Antibodies, Monoclonal/pharmacology ; Tumor Microenvironment
Chemical Substances	CD47 Antigen ; Antibodies, Monoclonal ; CD47 protein, human
Language	English
Publishing date	2023-01-10
Publishing country	United States
Document type	Journal Article
ZDB-ID	80069-7
ISSN	1528-0020 ; 0006-4971
ISSN (online)	1528-0020
ISSN	0006-4971
DOI	10.1182/blood.2022016101
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Uh III Zs.140: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG)
Zs.MO 364: Show issues

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Infiltration of CCR2+Ly6Chigh Proinflammatory Monocytes and Neutrophils into the Central Nervous System Is Modulated by Nicotinic Acetylcholine Receptors in a Model of Multiple Sclerosis.

Jiang, Wei / St-Pierre, Stéphanie / Roy, Patrick / Morley, Barbara J / Hao, Junwei / Simard, Alain R

Journal of immunology (Baltimore, Md. : 1950)

2016 Volume 196, Issue 5, Page(s) 2095–2108

Abstract: Myeloid cells, including proinflammatory monocytes and neutrophils, have important roles in the pathology of multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis (EAE). These cells infiltrate the CNS in the early stages of ... ...

Abstract	Myeloid cells, including proinflammatory monocytes and neutrophils, have important roles in the pathology of multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis (EAE). These cells infiltrate the CNS in the early stages of disease development and contribute to the inflammatory response that is associated with symptom severity. It is thus crucial to identify and understand new mechanisms that can regulate the CNS infiltration of proinflammatory myeloid cells. Nicotinic acetylcholine receptors (nAChRs) have been increasingly studied for their immune-regulatory properties. In this study, we assessed the ability of nicotine, an nAChR ligand, to modulate proinflammatory myeloid cell numbers within the bone marrow, spleen, blood, and CNS of EAE mice. We found that nicotine significantly inhibits the infiltration of proinflammatory monocytes and neutrophils into the CNS at time points where these cells are known to play critical roles in disease pathology. In contrast, nicotine does not affect the expansion of other monocytes. We also show that nicotine exerts these effects by acting on α7 and α9 nAChR subtypes. Finally, mRNA transcript levels for CCL2 and CXCL2, chemokines involved in the chemotaxis of proinflammatory monocytes and neutrophils, respectively, are reduced in the brain of nicotine-treated EAE mice before the massive infiltration of these cells. Taken together, our data provide evidence that nAChRs can regulate proinflammatory cell infiltration into the CNS, which could be of significant value for the treatment of neuroinflammatory disorders.
MeSH term(s)	Animals ; Antigens, Ly/immunology ; Brain/immunology ; Cell Separation ; Chemotaxis, Leukocyte/drug effects ; Chemotaxis, Leukocyte/immunology ; Encephalomyelitis, Autoimmune, Experimental/immunology ; Flow Cytometry ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Monocytes/immunology ; Multiple Sclerosis/immunology ; Neutrophils/immunology ; Nicotine/pharmacology ; Nicotinic Agonists/pharmacology ; Real-Time Polymerase Chain Reaction ; Receptors, CCR2/immunology ; Receptors, Nicotinic/immunology ; Reverse Transcriptase Polymerase Chain Reaction ; Spinal Cord/immunology
Chemical Substances	Antigens, Ly ; Ccr2 protein, mouse ; Ly-6C antigen, mouse ; Nicotinic Agonists ; Receptors, CCR2 ; Receptors, Nicotinic ; Nicotine (6M3C89ZY6R)
Language	English
Publishing date	2016-03-01
Publishing country	United States
Document type	Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
ZDB-ID	3056-9
ISSN	1550-6606 ; 0022-1767 ; 1048-3233 ; 1047-7381
ISSN (online)	1550-6606
ISSN	0022-1767 ; 1048-3233 ; 1047-7381
DOI	10.4049/jimmunol.1501613
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Full text

In stock of ZB MED Cologne/Königswinter

Ud II Zs.37: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG)
Zs.MG 28: Show issues

Order via subito

Details ▾

Article ; Online: Nicotinic Acetylcholine Receptors Modulate Bone Marrow-Derived Pro-Inflammatory Monocyte Production and Survival.

St-Pierre, Stéphanie / Jiang, Wei / Roy, Patrick / Champigny, Camille / LeBlanc, Éric / Morley, Barbara J / Hao, Junwei / Simard, Alain R

PloS one

2016 Volume 11, Issue 2, Page(s) e0150230

Abstract: It is increasingly clear that nicotinic acetylcholine receptors (nAChRs) are involved in immune regulation, and that their activation can protect against inflammatory diseases. Previous data have shown that nicotine diminishes the numbers of peripheral ... ...

Abstract	It is increasingly clear that nicotinic acetylcholine receptors (nAChRs) are involved in immune regulation, and that their activation can protect against inflammatory diseases. Previous data have shown that nicotine diminishes the numbers of peripheral monocytes and macrophages, especially those of the pro-inflammatory phenotype. The goal of the present study was to determine if nicotine modulates the production of bone marrow -derived monocytes/macrophages. In this study, we first found that murine bone marrow cells express multiple nAChR subunits, and that the α7 and α9 nAChRs most predominant subtypes found in immune cells and their precursors. Using primary cultures of murine bone marrow cells, we then determined the effect of nicotine on monocyte colony-stimulating factor and interferon gamma (IFNγ)-induced monocyte production. We found that nicotine lowered the overall number of monocytes, and more specifically, inhibited the IFNγ-induced increase in pro-inflammatory monocytes by reducing cell proliferation and viability. These data suggested that nicotine diminishes the ratio of pro-inflammatory versus anti-inflammatory monocyte produced in the bone marrow. We thus confirmed this hypothesis by measuring cytokine expression, where we found that nicotine inhibited the production of the pro-inflammatory cytokines TNFα, IL-1β and IL-12, while stimulating the secretion of IL-10, an anti-inflammatory cytokine. Finally, nicotine also reduced the number of pro-inflammatory monocytes in the bone marrow of LPS-challenged mice. Overall, our data demonstrate that both α7 and α9 nAChRs are involved in the regulation of pro-inflammatory M1 monocyte numbers.
MeSH term(s)	Animals ; Cell Count ; Cell Differentiation/drug effects ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Colony-Stimulating Factors/pharmacology ; Gene Expression Regulation/drug effects ; Inflammation/immunology ; Inflammation/metabolism ; Interferon-gamma/pharmacology ; Interleukin-10/metabolism ; Mice ; Mice, Inbred C57BL ; Monocytes/cytology ; Monocytes/drug effects ; Monocytes/metabolism ; Nicotine/pharmacology ; Protein Subunits/genetics ; Protein Subunits/metabolism ; Receptors, Nicotinic/genetics ; Receptors, Nicotinic/metabolism
Chemical Substances	Colony-Stimulating Factors ; Protein Subunits ; Receptors, Nicotinic ; Interleukin-10 (130068-27-8) ; Nicotine (6M3C89ZY6R) ; Interferon-gamma (82115-62-6)
Language	English
Publishing date	2016-02-29
Publishing country	United States
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ISSN	1932-6203
ISSN (online)	1932-6203
DOI	10.1371/journal.pone.0150230
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

To top

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Inter-library loan at ZB MED

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

Inter-library loan at ZB MED